AM1241
CAS No. 444912-48-5
AM1241( AM-1241 | AM 1241 )
Catalog No. M14524 CAS No. 444912-48-5
A potent, selective cannabinoid receptor CB2 agonist with Ki of 7.1 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
2MG | 29 | Get Quote |
|
5MG | 42 | Get Quote |
|
10MG | 73 | Get Quote |
|
25MG | 162 | Get Quote |
|
50MG | 275 | Get Quote |
|
100MG | 496 | Get Quote |
|
500MG | 1071 | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameAM1241
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent, selective cannabinoid receptor CB2 agonist with Ki of 7.1 nM.
-
DescriptionA potent, selective cannabinoid receptor CB2 agonist with Ki of 7.1 nM, >80-fold selectivity over CB1 receptors in radioligand binding assay; suppresses spinal fos protein expression and pain behavior in a rat model of inflammation, dose-dependently reversed tactile and thermal hypersensitivity produced by ligation of the L5 and L6 spinal nerves in rats.
-
In Vitro——
-
In Vivo——
-
SynonymsAM-1241 | AM 1241
-
PathwayGPCR/G Protein
-
TargetCannabinoid Receptor
-
RecptorCB1| CB2
-
Research AreaNeurological Disease
-
Indication——
Chemical Information
-
CAS Number444912-48-5
-
Formula Weight503.3
-
Molecular FormulaC22H22IN3O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCN1CCCCC1Cn2cc(c3c2cccc3)C(=O)c4cc(ccc4I)[N+](=O)[O-]
-
Chemical Name(2-iodo-5-nitrophenyl)-(1-(1-methylpiperidin-2-ylmethyl)-1H-indol-3-yl)methanone
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Malan TP Jr, et al. Pain. 2001 Sep;93(3):239-45.
2. Nackley AG, et al. Neuroscience. 2003;119(3):747-57.
3. Yao BB, et al. Br J Pharmacol. 2006 Sep;149(2):145-54.
4. Ibrahim MM, et al. Proc Natl Acad Sci U S A. 2003 Sep 2;100(18):10529-33.
molnova catalog
related products
-
PSNCBAM-1
PSNCBAM-1 is a CB1 receptor negative allosteric modulator (EC50 = 0.1 μM) with hypophagic effects in vivo. PSNCBAM-1 can be used for obesity studies.
-
LY2828360
LY2828360 is a cannabinoid (CB) receptor 2 agonist (Ki = 40.3 nM). It selectively activates CB2 over CB1 in a GTPγS binding assay (EC50s = 20.1 and >100000 nM respectively).
-
TM38837
TM38837 is an antagonist of cannabinoid receptor type 1 (CB1), with potential for the treatment of obesity and type 2 diabetes.